Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
PBPH
57
HOLDINGS
25%
ALSO IN CANC
CANC
55
HOLDINGS
24%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 5.3% | 5.3% |
|
MERCK & CO. INC. | 5.2% | 5.2% | 5.2% |
 |
NOVARTIS AG | 4.2% | 4.2% | 4.2% |
|
ABBVIE INC | 7.4% | 4.0% | 4.0% |
|
JOHNSON & JOHNSON | 9.3% | 2.5% | 2.5% |
PBPH Overweight Relative to CANC
|
ELI LILLY & CO | 11.6% |
|
JOHNSON & JOHNSON | 6.8% |
|
PFIZER INC | 3.4% |
|
ABBVIE INC | 3.4% |
|
GILEAD SCIENCES INC | 3.3% |
|
AMGEN INC | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
 |
NOVO NORDISK A/S-B | 2.5% |
 |
ASTRAZENECA PLC | 2.4% |
 |
SANOFI-AVENTIS | 1.9% |
PBPH Underweight Relative to CANC
|
GENMAB A/S SPONSORED ADR | -5.7% |
|
REVOLUTION MEDICINES, INC. | -4.6% |
|
COGENT BIOSCIENCES INC | -4.5% |
|
HALOZYME THERAPEUTICS INC | -3.8% |
|
BEIGENE LTD. SPONSORED ADR | -3.7% |
|
EXELIXIS INC | -3.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.1% |
|
BRIDGEBIO PHARMA, INC. | -2.7% |
|
CG ONCOLOGY, INC. | -2.4% |
|
ENLIVEN THERAPEUTICS, INC. | -2.4% |